Lv11
16 积分 2024-03-08 加入
Immunohistochemical biomarker validation in highly selective needle biopsy microarrays derived from mpMRI‐characterized prostates
1小时前
待确认
Correlation of primary tumor prostate-specific membrane antigen expression with disease recurrence in prostate cancer
2小时前
已完结
Comparison of PSMA immunohistochemistry scoring systems to parametric [18F]PSMA-1007 PET/MRI in primary prostate cancer
2小时前
已完结
Mutational landscape of head and neck cancer and cervical cancer in Chinese and Western population
1个月前
已完结
Pan-cancer single-cell landscape of tumor-infiltrating T cells
1个月前
已完结
Integrative multi-omics analyses identify molecular subtypes of head and neck squamous cell carcinoma with distinct therapeutic vulnerabilities
1个月前
已完结
Phase II randomized study of maintenance atezolizumab (A) versus atezolizumab + talazoparib (AT) in patients with SLFN11 positive extensive stage small cell lung cancer. S1929
1个月前
已完结
177Lu-PSMA-617 versus a change of androgen receptor pathway inhibitor therapy for taxane-naive patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): a phase 3, randomised, controlled trial
2个月前
已完结
Lu-177-Labeled Hetero-Bivalent Agents Targeting PSMA and Bone Metastases for Radionuclide Therapy
2个月前
已完结
Preclinical Efficacy of a PSMA-Targeted Actinium-225 Conjugate (225Ac-Macropa-Pelgifatamab): A Targeted Alpha Therapy for Prostate Cancer
3个月前
已完结
皖公网安备34019202002308
